APA

Moore K. N., Frank S. G., Alward E. K., Landrum L. M., Myers T. K., Walker J. L., Gold M. A., McMeekin D. S., Vesely S. K. & Mannel R. S. (20090527). Adjuvant chemotherapy for the "oldest old" ovarian cancer patients: can we anticipate toxicity-related treatment failure in a vulnerable population?. : Cancer.

Chicago

Moore Kathleen N, Frank Summer G, Alward Erin K, Landrum Lisa M, Myers Tashanna K, Walker Joan L, Gold Michael A, McMeekin D Scott, Vesely Sara K and Mannel Robert S. 20090527. Adjuvant chemotherapy for the "oldest old" ovarian cancer patients: can we anticipate toxicity-related treatment failure in a vulnerable population?. : Cancer.

Harvard

Moore K. N., Frank S. G., Alward E. K., Landrum L. M., Myers T. K., Walker J. L., Gold M. A., McMeekin D. S., Vesely S. K. and Mannel R. S. (20090527). Adjuvant chemotherapy for the "oldest old" ovarian cancer patients: can we anticipate toxicity-related treatment failure in a vulnerable population?. : Cancer.

MLA

Moore Kathleen N, Frank Summer G, Alward Erin K, Landrum Lisa M, Myers Tashanna K, Walker Joan L, Gold Michael A, McMeekin D Scott, Vesely Sara K and Mannel Robert S. Adjuvant chemotherapy for the "oldest old" ovarian cancer patients: can we anticipate toxicity-related treatment failure in a vulnerable population?. : Cancer. 20090527.